IL-12 sensing in neurons induces neuroprotective CNS tissue adaptation and attenuates neuroinflammation in mice.


Journal

Nature neuroscience
ISSN: 1546-1726
Titre abrégé: Nat Neurosci
Pays: United States
ID NLM: 9809671

Informations de publication

Date de publication:
10 2023
Historique:
received: 05 10 2022
accepted: 15 08 2023
medline: 4 10 2023
pubmed: 26 9 2023
entrez: 25 9 2023
Statut: ppublish

Résumé

Interleukin-12 (IL-12) is a potent driver of type 1 immunity. Paradoxically, in autoimmune conditions, including of the CNS, IL-12 reduces inflammation. The underlying mechanism behind these opposing properties and the involved cellular players remain elusive. Here we map IL-12 receptor (IL-12R) expression to NK and T cells as well as neurons and oligodendrocytes. Conditionally ablating the IL-12R across these cell types in adult mice and assessing their susceptibility to experimental autoimmune encephalomyelitis revealed that the neuroprotective role of IL-12 is mediated by neuroectoderm-derived cells, specifically neurons, and not immune cells. In human brain tissue from donors with multiple sclerosis, we observe an IL-12R distribution comparable to mice, suggesting similar mechanisms in mice and humans. Combining flow cytometry, bulk and single-nucleus RNA sequencing, we reveal an IL-12-induced neuroprotective tissue adaption preventing early neurodegeneration and sustaining trophic factor release during neuroinflammation, thereby maintaining CNS integrity in mice.

Identifiants

pubmed: 37749256
doi: 10.1038/s41593-023-01435-z
pii: 10.1038/s41593-023-01435-z
pmc: PMC10545539
doi:

Substances chimiques

Interleukin-12 187348-17-0

Types de publication

Journal Article Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Pagination

1701-1712

Informations de copyright

© 2023. The Author(s).

Références

Attfield, K. E., Jensen, L. T., Kaufmann, M., Friese, M. A. & Fugger, L. The immunology of multiple sclerosis. Nat. Rev. Immunol. 22, 734–750 (2022).
pubmed: 35508809 doi: 10.1038/s41577-022-00718-z
Dendrou, C. A., Fugger, L. & Friese, M. A. Immunopathology of multiple sclerosis. Nat. Rev. Immunol. 15, 545–558 (2015).
pubmed: 26250739 doi: 10.1038/nri3871
Trinchieri, G. Interleukin-12: a proinflammatory cytokine with immunoregulatory functions that bridge innate resistance and antigen-specific adaptive immunity. Annu. Rev. Immunol. 13, 251–276 (1995).
pubmed: 7612223 doi: 10.1146/annurev.iy.13.040195.001343
Oppmann, B. et al. Novel p19 protein engages IL-12p40 to form a cytokine, IL-23, with biological activities similar as well as distinct from IL-12. Immunity 13, 715–725 (2000).
pubmed: 11114383 doi: 10.1016/S1074-7613(00)00070-4
Becher, B., Durell, B. G. & Noelle, R. J. Experimental autoimmune encephalitis and inflammation in the absence of interleukin-12. J. Clin. Invest. https://doi.org/10.1172/JCI200215751 (2002).
Gran, B. et al. IL-12p35-deficient mice are susceptible to experimental autoimmune encephalomyelitis: evidence for redundancy in the IL-12 system in the induction of central nervous system autoimmune demyelination. J. Immunol. 169, 7104–7110 (2002).
pubmed: 12471147 doi: 10.4049/jimmunol.169.12.7104
Segal, B. M. et al. Repeated subcutaneous injections of IL12/23 p40 neutralising antibody, ustekinumab, in patients with relapsing-remitting multiple sclerosis: a phase II, double-blind, placebo-controlled, randomised, dose-ranging study. Lancet Neurol. 7, 796–804 (2008).
pubmed: 18703004 doi: 10.1016/S1474-4422(08)70173-X
Milosevic, E. et al. Higher expression of IL-12Rβ2 is associated with lower risk of relapse in relapsing–remitting multiple sclerosis patients on interferon-β1b therapy during 3-year follow-up. J. Neuroimmunol. 287, 64–70 (2015).
pubmed: 26439963 doi: 10.1016/j.jneuroim.2015.07.011
Zwicky, P. et al. IL-12 regulates type 3 immunity through interfollicular keratinocytes in psoriasiform inflammation. Sci. Immunol. 6, eabg9012 (2021).
pubmed: 34678045 doi: 10.1126/sciimmunol.abg9012
Van Kaer, L., Postoak, J. L., Wang, C., Yang, G. & Wu, L. Innate, innate-like and adaptive lymphocytes in the pathogenesis of MS and EAE. Cell. Mol. Immunol. 16, 531–539 (2019).
pubmed: 30874627 pmcid: 6804597 doi: 10.1038/s41423-019-0221-5
Utz, S. G. et al. Early fate defines microglia and non-parenchymal brain macrophage development. Cell 181, 557–573 (2020).
pubmed: 32259484 doi: 10.1016/j.cell.2020.03.021
Schneeberger, S. et al. The neuroinflammatory interleukin-12 signaling pathway drives Alzheimer’s disease-like pathology by perturbing oligodendrocyte survival and neuronal homeostasis. Preprint at bioRxiv https://doi.org/10.1101/2021.04.25.441313 (2021).
Absinta, M. et al. A lymphocyte–microglia–astrocyte axis in chronic active multiple sclerosis. Nature https://doi.org/10.1038/s41586-021-03892-7 (2021).
Schirmer, L. et al. Neuronal vulnerability and multilineage diversity in multiple sclerosis. Nature 573, 75–82 (2019).
pubmed: 31316211 pmcid: 6731122 doi: 10.1038/s41586-019-1404-z
Harno, E., Cottrell, E. C. & White, A. Metabolic pitfalls of CNS Cre-based technology. Cell Metab. 18, 21–28 (2013).
pubmed: 23823475 doi: 10.1016/j.cmet.2013.05.019
Kozareva, V. et al. A transcriptomic atlas of mouse cerebellar cortex comprehensively defines cell types. Nature 598, 214–219 (2021).
pubmed: 34616064 pmcid: 8494635 doi: 10.1038/s41586-021-03220-z
Erö, C., Gewaltig, M. O., Keller, D. & Markram, H. A cell atlas for the mouse brain. Front. Neuroinform. https://doi.org/10.3389/fninf.2018.00084 (2018).
Ousman, S. S. et al. Protective and therapeutic role for αB-crystallin in autoimmune demyelination. Nature 448, 474–479 (2007).
pubmed: 17568699 doi: 10.1038/nature05935
Lammert, C. R. et al. AIM2 inflammasome surveillance of DNA damage shapes neurodevelopment. Nature 580, 647–652 (2020).
pubmed: 32350463 pmcid: 7788527 doi: 10.1038/s41586-020-2174-3
Golan, N. et al. Genetic deletion of Cadm4 results in myelin abnormalities resembling Charcot-Marie-Tooth neuropathy. J. Neurosci. 33, 10950–10961 (2013).
pubmed: 23825401 pmcid: 3718361 doi: 10.1523/JNEUROSCI.0571-13.2013
Kenigsbuch, M. et al. A shared disease-associated oligodendrocyte signature among multiple CNS pathologies. Nat. Neurosci. https://doi.org/10.1038/s41593-022-01104-7 (2022).
Wertz, M. H. et al. Genome-wide in vivo CNS screening identifies genes that modify CNS neuronal survival and mHTT toxicity. Neuron 106, 76–89 (2020).
pubmed: 32004439 pmcid: 7181458 doi: 10.1016/j.neuron.2020.01.004
Squair, J. W. et al. Confronting false discoveries in single-cell differential expression. Nat. Commun. 12, 5692 (2021).
pubmed: 34584091 pmcid: 8479118 doi: 10.1038/s41467-021-25960-2
Browaeys, R., Saelens, W. & Saeys, Y. NicheNet: modeling intercellular communication by linking ligands to target genes. Nat. Methods 17, 159–162 (2019).
pubmed: 31819264 doi: 10.1038/s41592-019-0667-5
Kopec, B. M., Kiptoo, P., Zhao, L., Rosa-Molinar, E. & Siahaan, T. J. Noninvasive brain delivery and efficacy of BDNF to stimulate neuroregeneration and suppression of disease relapse in EAE mice. Mol. Pharm. 17, 404–416 (2020).
pubmed: 31846344
Cuttler, K., Hassan, M., Carr, J., Cloete, R. & Bardien, S. Emerging evidence implicating a role for neurexins in neurodegenerative and neuropsychiatric disorders. Open Biol. 11, 210091 (2021).
pubmed: 34610269 pmcid: 8492176 doi: 10.1098/rsob.210091
Liao, G. et al. Enhanced expression of matrix metalloproteinase-12 contributes to Npc1 deficiency-induced axonal degeneration. Exp. Neurol. 269, 67–74 (2015).
pubmed: 25864931 pmcid: 4446199 doi: 10.1016/j.expneurol.2015.04.004
Haile, Y. et al. Granzyme B-inhibitor serpina3n induces neuroprotection in vitro and in vivo. J. Neuroinflammation https://doi.org/10.1186/s12974-015-0376-7 (2012).
Burtscher, J., Mallet, R. T., Burtscher, M. & Millet, G. P. Hypoxia and brain aging: neurodegeneration or neuroprotection? Ageing Res. Rev. 68, 101343 (2021).
pubmed: 33862277 doi: 10.1016/j.arr.2021.101343
Leibinger, M., Andreadaki, A. & Fischer, D. Role of mTOR in neuroprotection and axon regeneration after inflammatory stimulation. Neurobiol. Dis. 46, 314–324 (2012).
pubmed: 22273489 doi: 10.1016/j.nbd.2012.01.004
Gazzinelli, R. T., Hieny, S., Wynn, T. A., Wolf, S. & Sher, A. Interleukin 12 is required for the T-lymphocyte-independent induction of interferon gamma by an intracellular parasite and induces resistance in T-cell-deficient hosts. Proc. Natl Acad. Sci. USA 90, 6115–6119 (1993).
pubmed: 8100999 pmcid: 46878 doi: 10.1073/pnas.90.13.6115
Tuzlak, S. et al. Repositioning T
pubmed: 34545250 doi: 10.1038/s41590-021-01009-w
McGeachy, M. J. et al. The interleukin 23 receptor is essential for the terminal differentiation of interleukin 17-producing effector T helper cells in vivo. Nat. Immunol. 10, 314–324 (2009).
pubmed: 19182808 pmcid: 2945605 doi: 10.1038/ni.1698
Tait Wojno, E. D., Hunter, C. A. & Stumhofer, J. S. The immunobiology of the interleukin-12 family: room for discovery. Immunity 50, 851–870 (2019).
pubmed: 30995503 doi: 10.1016/j.immuni.2019.03.011
Becher, B., Spath, S. & Goverman, J. Cytokine networks in neuroinflammation. Nat. Rev. Immunol. 17, 49–59 (2016).
pubmed: 27916979 doi: 10.1038/nri.2016.123
Murphy, C. A. et al. Divergent pro- and anti-inflammatory roles for IL-23 and IL-12 in joint autoimmune inflammation. J. Exp. Med. https://doi.org/10.1084/jem.20030896 (2003).
Tsuji-Yamada, J. et al. Effect of IL-12 encoding plasmid administration on tight-skin mouse. Biochem. Biophys. Res. Commun. 280, 707–712 (2001).
pubmed: 11162578 doi: 10.1006/bbrc.2000.4171
Alam, A. et al. Cellular infiltration in traumatic brain injury. J. Neuroinflammation 17, 328 (2020).
pubmed: 33143727 pmcid: 7640704 doi: 10.1186/s12974-020-02005-x
Falcão, A. M. et al. Disease-specific oligodendrocyte lineage cells arise in multiple sclerosis. Nat. Med. 24, 1837–1844 (2018).
pubmed: 30420755 pmcid: 6544508 doi: 10.1038/s41591-018-0236-y
Wheeler, M. A. et al. MAFG-driven astrocytes promote CNS inflammation. Nature 578, 593–599 (2020).
pubmed: 32051591 pmcid: 8049843 doi: 10.1038/s41586-020-1999-0
Flügel, A. et al. Neuronal FasL induces cell death of encephalitogenic T lymphocytes. Brain Pathol. 10, 353–364 (2006).
pmcid: 8098261 doi: 10.1111/j.1750-3639.2000.tb00267.x
Di Liberto, G. et al. Neurons under T cell attack coordinate phagocyte-mediated synaptic stripping. Cell 175, 458–471 (2018).
pubmed: 30173917 doi: 10.1016/j.cell.2018.07.049
Jin, K. et al. FGF-2 promotes neurogenesis and neuroprotection and prolongs survival in a transgenic mouse model of Huntington’s disease. Proc. Natl Acad. Sci. USA 102, 18189–18194 (2005).
pubmed: 16326808 pmcid: 1312383 doi: 10.1073/pnas.0506375102
Sun, D. et al. Basic fibroblast growth factor-enhanced neurogenesis contributes to cognitive recovery in rats following traumatic brain injury. Exp. Neurol. 216, 56–65 (2009).
pubmed: 19100261 doi: 10.1016/j.expneurol.2008.11.011
Ruffini, F. et al. Fibroblast growth factor-II gene therapy reverts the clinical course and the pathological signs of chronic experimental autoimmune encephalomyelitis in C57BL/6 mice. Gene Ther. 8, 1207–1213 (2001).
pubmed: 11509953 doi: 10.1038/sj.gt.3301523
Tyler, C. M. & Boulanger, L. M. New roles for MHC class I immune molecules in the healthy and diseased nervous system. eLS https://doi.org/10.1002/9780470015902.a0025802 (2014).
Adelson, J. D. et al. Neuroprotection from stroke in the absence of MHCI or PirB. Neuron 73, 1100–1107 (2012).
pubmed: 22445338 pmcid: 3314229 doi: 10.1016/j.neuron.2012.01.020
Croxford, A. L. et al. The cytokine GM-CSF drives the inflammatory signature of CCR2
pubmed: 26341401 doi: 10.1016/j.immuni.2015.08.010
Potter, H. et al. Safety and efficacy of sargramostim (GM‐CSF) in the treatment of Alzheimer’s disease. Alzheimer’s Dement. 7, e12158 (2021).
doi: 10.1002/trc2.12158
Berghmans, N., Dillen, C. & Heremans, H. Exogenous IL-12 suppresses experimental autoimmune encephalomyelitis (EAE) by tuning IL-10 and IL-5 levels in an IFN-γ-dependent way. J. Neuroimmunol. 176, 63–75 (2006).
pubmed: 16764944 doi: 10.1016/j.jneuroim.2006.04.009
Gran, B. et al. Early administration of IL-12 suppresses EAE through induction of interferon-γ. J. Neuroimmunol. 156, 123–131 (2004).
pubmed: 15465603 doi: 10.1016/j.jneuroim.2004.07.019
Yaguchi, M., Ohta, S., Toyama, Y., Kawakami, Y. & Toda, M. Functional recovery after spinal cord injury in mice through activation of microglia and dendritic cells after IL-12 administration. J. Neurosci. Res. 86, 1972–1980 (2008).
pubmed: 18438913 doi: 10.1002/jnr.21658
Lin, H., Hikawa, N., Takenaka, T. & Ishikawa, Y. Interleukin-12 promotes neurite outgrowth in mouse sympathetic superior cervical ganglion neurons. Neurosci. Lett. 278, 129–132 (2000).
pubmed: 10653010 doi: 10.1016/S0304-3940(99)00913-1
Kaufmann, M. et al. Identification of early neurodegenerative pathways in progressive multiple sclerosis. Nat. Neurosci. https://doi.org/10.1038/s41593-022-01097-3 (2022).
Schwenk, F., Baron, U. & Rajewsky, K. A cre-transgenic mouse strain for the ubiquitous deletion of loxP-flanked gene segments including deletion in germ cells. Nucleic Acids Res. 23, 5080–5081 (1995).
pubmed: 8559668 pmcid: 307516 doi: 10.1093/nar/23.24.5080
Tronche, F. et al. Disruption of the glucocorticoid receptor gene in the nervous system results in reduced anxiety. Nat. Genet. 23, 99–103 (1999).
pubmed: 10471508 doi: 10.1038/12703
Boer, Jde et al. Transgenic mice with hematopoietic and lymphoid specific expression of Cre. Eur. J. Immunol. 33, 314–325 (2003).
pubmed: 12548562 doi: 10.1002/immu.200310005
Sawada, S., Scarborough, J. D., Killeen, N. & Littman, D. R. A lineage-specific transcriptional silencer regulates CD4 gene expression during T lymphocyte development. Cell 77, 917–929 (1994).
pubmed: 8004678 doi: 10.1016/0092-8674(94)90140-6
Stamou, M., Grodzki, A. C., van Oostrum, M., Wollscheid, B. & Lein, P. J. Fc gamma receptors are expressed in the developing rat brain and activate downstream signaling molecules upon cross-linking with immune complex. J. Neuroinflammation 15, 7 (2018).
pubmed: 29306331 pmcid: 5756609 doi: 10.1186/s12974-017-1050-z
Schneider, C. A., Rasband, W. S. & Eliceiri, K. W. NIH Image to ImageJ: 25 years of image analysis. Nat. Methods 9, 671–675 (2012).
pubmed: 22930834 pmcid: 5554542 doi: 10.1038/nmeth.2089
Sommer, C., Straehle, C., Kothe, U. & Hamprecht, F. A. Ilastik: interactive learning and segmentation toolkit. In 2011 IEEE International Symposium on Biomedical Imaging: From Nano to Macro (eds Wright, S. et al.) 230–233 (IEEE, 2011).
Love, M. I., Huber, W. & Anders, S. Moderated estimation of fold change and dispersion for RNA-seq data with DESeq2. Genome Biol. https://doi.org/10.1186/s13059-014-0550-8 (2014).
Robinson, M. D., McCarthy, D. J. & Smyth, G. K. edgeR: a Bioconductor package for differential expression analysis of digital gene expression data. Bioinformatics 26, 139–140 (2010).
pubmed: 19910308 doi: 10.1093/bioinformatics/btp616
Russo, P. S. T. et al. CEMiTool: a Bioconductor package for performing comprehensive modular co-expression analyses. BMC Bioinformatics 19, 56 (2018).
pubmed: 29458351 pmcid: 5819234 doi: 10.1186/s12859-018-2053-1
Liberzon, A. et al. The molecular signatures database hallmark gene set collection. Cell Syst. 1, 417–425 (2015).
pubmed: 26771021 pmcid: 4707969 doi: 10.1016/j.cels.2015.12.004
Szklarczyk, D. et al. STRING v11: protein–protein association networks with increased coverage, supporting functional discovery in genome-wide experimental datasets. Nucleic Acids Res. 47, D607–D613 (2019).
pubmed: 30476243 doi: 10.1093/nar/gky1131
Wolf, F. A., Angerer, P. & Theis, F. J. SCANPY: large-scale single-cell gene expression data analysis. Genome Biol. 19, 15 (2018).
doi: 10.1186/s13059-017-1382-0
Wolock, S. L., Lopez, R. & Klein, A. M. Scrublet: computational identification of cell doublets in single-cell transcriptomic data. Cell Syst. https://doi.org/10.1016/j.cels.2018.11.005 (2019).
Lopez, R., Regier, J., Cole, M. B., Jordan, M. I. & Yosef, N. Deep generative modeling for single-cell transcriptomics. Nat. Methods 15, 1053–1058 (2018).
pubmed: 30504886 pmcid: 6289068 doi: 10.1038/s41592-018-0229-2
Zeisel, A. et al. Molecular architecture of the mouse nervous system. Cell 174, 999–1014 (2018).
pubmed: 30096314 pmcid: 6086934 doi: 10.1016/j.cell.2018.06.021
Saunders, A. et al. Molecular diversity and specializations among the cells of the adult mouse brain. Cell 174, 1015–1030 (2018).
pubmed: 30096299 pmcid: 6447408 doi: 10.1016/j.cell.2018.07.028
Tirosh, I. et al. Dissecting the multicellular ecosystem of metastatic melanoma by single-cell RNA-seq. Science 352, 189–196 (2019).
Hao, Y. et al. Integrated analysis of multimodal single-cell data. Cell 184, 3573–3587 (2021).
pubmed: 34062119 pmcid: 8238499 doi: 10.1016/j.cell.2021.04.048
Choudhary, S. & Satija, R. Comparison and evaluation of statistical error models for scRNA-seq. Genome Biol. 23, 27 (2022).
Becht, E. et al. Dimensionality reduction for visualizing single-cell data using UMAP. Nat. Biotechnol. https://doi.org/10.1038/nbt.4314 (2018).
Van Gassen, S. et al. FlowSOM: using self-organizing maps for visualization and interpretation of cytometry data. Cytometry A 87, 636–645 (2015).
pubmed: 25573116 doi: 10.1002/cyto.a.22625

Auteurs

Myrto Andreadou (M)

Institute of Experimental Immunology, University of Zurich, Zurich, Switzerland.

Florian Ingelfinger (F)

Institute of Experimental Immunology, University of Zurich, Zurich, Switzerland.
Department of Neurology, University Hospital Zurich, Zurich, Switzerland.
Department of Systems Immunology, Weizmann Institute, Rehovot, Israel.

Donatella De Feo (D)

Institute of Experimental Immunology, University of Zurich, Zurich, Switzerland.

Teresa L M Cramer (TLM)

Institute of Pharmacology and Toxicology, Neurodevelopmental Pharmacology, University of Zurich, Zurich, Switzerland.

Selma Tuzlak (S)

Institute of Experimental Immunology, University of Zurich, Zurich, Switzerland.

Ekaterina Friebel (E)

Institute of Experimental Immunology, University of Zurich, Zurich, Switzerland.
Department of Neuropathology, Charité-Universitätsmedizin Berlin, corporate member of Freie Universität Berlin and Humboldt-Universität zu Berlin, Berlin, Germany.

Bettina Schreiner (B)

Institute of Experimental Immunology, University of Zurich, Zurich, Switzerland.
Department of Neurology, University Hospital Zurich, Zurich, Switzerland.

Pascale Eede (P)

Department of Neuropathology, Charité-Universitätsmedizin Berlin, corporate member of Freie Universität Berlin and Humboldt-Universität zu Berlin, Berlin, Germany.

Shirin Schneeberger (S)

Department of Neuropathology, Charité-Universitätsmedizin Berlin, corporate member of Freie Universität Berlin and Humboldt-Universität zu Berlin, Berlin, Germany.
Cluster of Excellence, NeuroCure, Berlin, Germany.

Maria Geesdorf (M)

Department of Neuropathology, Charité-Universitätsmedizin Berlin, corporate member of Freie Universität Berlin and Humboldt-Universität zu Berlin, Berlin, Germany.

Frederike Ridder (F)

Institute of Experimental Immunology, University of Zurich, Zurich, Switzerland.

Christina A Welsh (CA)

Institute of Experimental Immunology, University of Zurich, Zurich, Switzerland.

Laura Power (L)

Institute of Experimental Immunology, University of Zurich, Zurich, Switzerland.

Daniel Kirschenbaum (D)

Institute of Neuropathology, University Hospital Zurich, Zurich, Switzerland.
Department of Systems Immunology, Weizmann Institute, Rehovot, Israel.

Shiva K Tyagarajan (SK)

Institute of Pharmacology and Toxicology, Neurodevelopmental Pharmacology, University of Zurich, Zurich, Switzerland.

Melanie Greter (M)

Institute of Experimental Immunology, University of Zurich, Zurich, Switzerland.

Frank L Heppner (FL)

Department of Neuropathology, Charité-Universitätsmedizin Berlin, corporate member of Freie Universität Berlin and Humboldt-Universität zu Berlin, Berlin, Germany.
Cluster of Excellence, NeuroCure, Berlin, Germany.
German Center for Neurodegenerative Diseases (DZNE) Berlin, Berlin, Germany.

Sarah Mundt (S)

Institute of Experimental Immunology, University of Zurich, Zurich, Switzerland. mundt@immunology.uzh.ch.

Burkhard Becher (B)

Institute of Experimental Immunology, University of Zurich, Zurich, Switzerland. becher@immunology.uzh.ch.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH